Pathophysiology and therapeutic strategies for peritoneal recurrence after gastric cancer surgery.

Authors

null

Satoshi Murata

Department of Surgery, Shiga University of Medical Science, Otsu, Japan

Satoshi Murata , Katsushi Takebayashi , Hiroshi Yamamoto , Tsuyoshi Yamaguchi , Sachiko Kaida , Hirokazu Kodama , Reiko Ohtake , Tomoharu Shimizu , Tsuyoshi Mori , Yuki Kawai , Naomi Kitamura , Toru Miyake , Hiroya Akabori , Hiroya Iida , Tomoyuki Ueki , Hiromichi Sonoda , Haruki Mori , Nobuhito Nitta , Shigeyuki Naka , Masaji Tani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4050)

DOI

10.1200/JCO.2017.35.15_suppl.4050

Abstract #

4050

Poster Bd #

42

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

First Author: Hiroyuki Arai

First Author: Megan Greally

Poster

2016 Gastrointestinal Cancers Symposium

Prospective results of perioperative chemotherapy (PCT) with cisplatin and irinotecan for locally advanced gastric cancer.

Prospective results of perioperative chemotherapy (PCT) with cisplatin and irinotecan for locally advanced gastric cancer.

First Author: Guilherme Luiz Stelko Pereira